NIH « Science and Enterprise

Nasal Spray Vaccine Shown to Stop Gonorrhea Infections

By Alan, on January 16th, 2023%

A vaccine against gonorrhea given as a nasal spray is shown to generate protective immune responses in lab mice of both sexes, and in females similar to an intravaginal vaccine. . . . → Read More: Nasal Spray Vaccine Shown to Stop Gonorrhea Infections

Project to Sequence 20K Dog and Cat Genomes

By Alan, on January 9th, 2023%

Some 20,000 dogs and cats are expected to have their genomes sequenced in the next 10 years for a publicly available database to enable precision medicine for pets. . . . → Read More: Project to Sequence 20K Dog and Cat Genomes

Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors

By Alan, on October 27th, 2022%

Research with lab animals shows an experimental cancer vaccine generates immune-system cells that infiltrate solid tumors and reduce the tumor’s protective environment. . . . → Read More: Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors

Nasal Spray Vaccines Get CEPI, NIH Funding

By Alan, on October 6th, 2022%

A developer of infectious disease vaccines is gaining funds for new nasal sprays protecting against a range of coronaviruses and the sexually-transmitted disease gonorrhea. . . . → Read More: Nasal Spray Vaccines Get CEPI, NIH Funding

NIH Funds Decentralized Rare Disease Data Network

By Alan, on September 23rd, 2022%

A start-up company is building a secure decentralized network of genomic and other medical data on rare diseases, funded by a fast-track award from an NIH agency. . . . → Read More: NIH Funds Decentralized Rare Disease Data Network

Exec. Order Aims to Boost U.S. Biotech, Manufacturing

By Alan, on September 13th, 2022%

An executive order issued by President Joe Biden yesterday seeks to make biotechnology and biomanufacturing a centerpiece of the American economy. . . . → Read More: Exec. Order Aims to Boost U.S. Biotech, Manufacturing

Trial to Test Smart Watch to Guide Blood Thinners

By Alan, on August 30th, 2022%

A clinical trial is planned to test heart rhythms measured with an Apple smart watch to guide use of blood thinning medicines in people with irregular heartbeat. . . . → Read More: Trial to Test Smart Watch to Guide Blood Thinners

Women’s Health Companies Partner on New Contraceptive

By Alan, on July 28th, 2022%

Two companies working in women’s reproductive health are developing a new non-hormonal contraceptive that works in cervical mucous membranes. . . . → Read More: Women’s Health Companies Partner on New Contraceptive

Small Biz Grant Funds Non-Viral Gene Editing Delivery

By Alan, on July 26th, 2022%

National Institutes of Health is financing a delivery method for gene-editing therapies to blood-forming stem cells with natural lipid bubbles instead of viruses. . . . → Read More: Small Biz Grant Funds Non-Viral Gene Editing Delivery

NIH Funding Engineered Phage Screening Device

By Alan, on July 15th, 2022%

National Institutes of Health is funding initial development of a microfluidic device that tests engineered viruses for their ability to kill disease-causing bacteria. . . . → Read More: NIH Funding Engineered Phage Screening Device

Subscribe for email alerts

Donate to Science & Enterprise

Like us on Facebook

S&E on Mastodon

S&E on LinkedIn

Posts RSS feed

Specials

Guest Posts

Please share Science & Enterprise